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ABSTRACT 
Substitution of hazardous substances against less hazardous ones is a central requirement of the European Chem-
ical Regulation REACH (European Regulation 1907/2006/EC). Hazardous substances emitted from products may 
not only affect the worker; drift off and distribution in the environment may finally result in exposure of the general 
population. This potential threat to health is covered by the impact category “toxicity” in Life Cycle Assessments. 
In this paper, we present a case of a substitution of volatile organic compounds in a reactive varnish, and compare 
the “old” formulation with the “new” formulation against health risk to the worker, and concerning the Life Cycle 
Assessment impact category “toxicity”. The “old” formulation contained Naphtha (petroleum), hydrodesulfurized, 
heavy and Solvent naphtha (petroleum), light, aromatic. In the new formulation, both naphthas were replaced by 
n-Butylacetate, 1-Ethoxy-2-propyl acetate and Ethyl-3-ethoxy propionate. In the European Union, the naphthas 
are classified as mutagens and carcinogens category 1, officially. However, if benzene is below 0.1 %, registrants 
in the EU proposed to omit this classification, and todays naptha products on the market obviously have benzene 
contents below 0.1 %. On a first glance, the improvement for workplace safety introduced by the substitution, 
therefore, is comparatively small, as it is for toxicity in Life Cycle Assessment. However, when background 
knowledge concerning chemical production processes of naphtha is included, benzene below a content of 0.1 % 
needs to be taken into consideration, and the benefit of substitution is more obvious.  
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INTRODUCTION 
Varnishes typically contain solvents that 
not only ensure easy spreading and brushing 
on surfaces; a fine orchestrated evaporation 
process ensures hardening of the varnish with 
release of an optical and mechanical opti-
mized surface. Due to the purpose the solvent 
serves, exposure to volatile organic com-
pounds is unavoidable. For the sake of worker 
protection, employers are requested to look 
for substitutions for solvents with a relatively 
high risk potential against others with a lower 
risk potential.  
Life Cycle Assessment according to 
standards ISO 14040 and ISO 14044 assesses 
the total environmental impact of a product or 
service. In that respect, the benchmark for 
comparison of products is the “functional 
unit” (fu), i. e. the service of the product. For 
example, the functional unit for a varnish 
could be “protection of 1 m² wood against 
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weathering for 10 years”. To fulfil this re-
quirement, varnish A has to be applied in an 
amount of X kg per m², whereas from varnish 
B, Y kg per m² has to be used; so, X kg var-
nish A have to be compared to Y kg varnish 
B. Production and use of an article is than 
evaluated against the “impact categories”, be-
neath these depletion of resources, emissions 
into the environment and subsequent impacts 
like global warming-, acidification-, eutroph-
ication-, and also toxicity-potential. The free 
program USETox (Rosenbaum et al., 2008, 
2011) allows the calculation of the health im-
pact of toxic substances emitted to air, water 
and soil to the general population. The 
amount emitted is translated into exposure, 
taking into account the potential fate of the 
substance between emission from the tech-
nical process(es) and uptake by human be-
ings.  
In this paper, the result of a technically 
feasible substitution process is presented for a 
wood protecting varnish for outdoor applica-
tions against health risk for the worker and the 
impact category “toxicity” in Life Cycle As-
sessment.  
The original formulation (Form 1) con-
tained 8 % of naphta 1 and naphtha 2 each 
(Table 1). The alternative solvent composi-
tion is shown in Table 2. For Ethoxypropy-
lacetate and Ethyl-3-ethoxypropionate, clas-
sification and labelling data from registration 
dossiers were cited (European Chemicals 
Agency, 2016a; European Chemicals 
Agency, 2016b). For the other substances, 
hazard phrases are taken from annex 6, Euro-
pean Union Regulation 1272/2008/EC. The 
classification according to the global harmo-
nized system (GHS) of the naphtha solvents 
as mutagens and carcinogens category 1B 
calls for a substitution already, and Formula-
tion 2 appears to be less hazardous. For naph-
tha 1 with benzene < 0.1 %, registrants pro-
pose a classification as H226 (flammable liq-
uid), H304 (may be fatal if swallowed), H315 
(causes skin irritation), H336 (may cause 
drowsiness and dizziness) and H372 (may af-
fect the central vervous system). For naphtha 
2 with benzene < 0.1 %, toluene and n-hexane 
< 3 %, the registrants propose a classification 
as H225 (highly flammable liquid) H315, 
H304 and H336.  
In the following, a closer look on this sub-
stitution in terms of toxicological risk assess-
ment on the one hand, and against Life Cycle 
Impact Assessment on the other hand will be 
presented. The latter is confined to the impact 
category “toxicity”, calculated via the pub-
licly available program USETox 2.0 (Rosen-
baum et al., 2008, 2011).  
The toxicological risk assessment 
matches NOAEL and NOAECs against expo-
sure levels while applying the varnish, taking 
a workplace protection point of view. Tox-
icity in Life Cycle Impact Assessment covers 
the total emission of substances under inves-
tigation, their distribution in the region after 
release, degradation processes and final in-
take by the population via inhalation and in-
gestion of contaminated air, water and food 
(Rosenbaum et al., 2008). 
 
Table 1: Formulation 1 (Form 1), the original solvent formulation 
Component Content (%) CAS-No. Description 
Classification and la-
belling* 
naphtha 1 8 64742-82-1 Naphtha (petroleum),  hydrodesulfurized heavy  
H340 
H350 
H372 (nervous system) 
H304 
naphtha 2 8 64742-95-6 Solvent naphtha (petroleum), light aromatic. 
H340 
H350 
H304 
*according annex VI, commission regulation 1272/2008; H304: May be fatal if swallowed and enters the airways; H340: May 
cause genetic defects; H350: May cause cancer; H372: causes damage to the nervous system through prolonged or repeated 
exposure  
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Table 2: Formulation 2 (Form 2), the alternative solvent formulation 
Component Content (%) CAS-No. Classification and Labelling* 
n-Butylacetate 10 123-86-4 
H225 
H336 
EUH066 
Ethoxypropylacetate (1-Ethoxy-2-propyl-acetate) 6 54839-24-6 H226 
Ethyl-3-ethoxypropionate 6 763-69-9 H226; EUH066 
*:H225: highly flammable liquid; H226: flammable liquid; H336: may cause drowsiness and dizziness; EUH066: repeated expo-
sure may cause skin dryness or cracking 
 
 
METHODS 
The scenario modelled shall be painting of 
wooden planks with two types of varnishes 
which differ in the composition of volatile or-
ganic compounds. As the other components 
of the varnish are unavoidable resins and 
hardeners which can not be substituted if the 
required physical properties shall be matched, 
the whole analysis concentrates on the rela-
tive differences made up by the solvents. The 
new formulation has a higher content of sol-
vents; to apply the same amount of resin and 
hardener per area, a factor of 1.375 higher 
mass of the new formulation replaces the old 
formulation. 10 kg (Formulation 1) or 
13.75 kg (Formulation 2) varnish is applied 
on a surface of 10 m² for 6 h per day; remain-
ing working hours are required for prepara-
tion, clean-up etc. The workplace is outdoors 
in good naturally ventilated areas. The tem-
perature shall be 25° C.  
 
Substance data 
Substance data concerning environmental 
behavior and toxicity are taken from the 
REACH registration dossiers published on 
the ECHA website. Substance evaluations 
published by the Deutsche Forschungsge-
meinschaft in “The MAK Collection for Oc-
cupational Health and Safety” are used as pre-
ferred sources for toxicological data.  
 
Worker Risk Assessment 
The toxicological data of the naphtha sol-
vents as well as for the substitutes will be re-
visited. With the help of the workers exposure 
modelling program “Advanced REACH 
Tool” (ART) (McNally et al., 2014) exposure 
will be calculated and matched against the de-
rived no effect levels (DNEL) or derived 
maximum exposure levels (DMEL) and exist-
ing official occupational exposure limits in 
Germany.  
For the ART calculations, the following 
situation was simulated: 
• total exposure time 6 h/d. 
• outdoor application, good general ventila-
tion, distant from buildings. 
• temperature: 25° C. 
• brushing of varnish, less than 1 m away 
from breathing zone, 1 – 3 m² per hour. 
• no carry over from nearby applications. 
• Program set to calculate the 75th percentile 
for the exposure. 
 
Life Cycle Impact Assessment: Toxicity es-
timate by USETox 
There are several ways to address toxicity 
in Life Cycle Assessment. The model and 
program USETox is a consensus model devel-
oped by a group of researches under the um-
brella of the Society of Environmental Toxi-
cology and Chemistry (SETAC) (Rosenbaum 
et al., 2008, 2011). In this program, the impact 
category “toxicity” is defined as 
CF = XF * FF * EF,  
 CF = iF * EF = CTUh 
where CF is the characterization factor as 
number of disease cases per kg emitted 
[cases/kgemitted], XF means emission per day 
[kg/d], FF is the fate factor, covering losses of 
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the emitted substance due to degradation pro-
cesses [d], EF is the effect factor as number of 
cases per kg taken up [cases/kgintake], iF is the 
intake fraction [kgintake/kgemitted], and CTUh 
are the comparative toxic units, the estimate 
in increase of morbidity [cases/kgemitted]. 
The fate factor, FF, is estimated with by a 
multimedia fate model that covers distribu-
tion and degradation of the substance in the 
environment. Several physical-chemical and 
environmental data are required to simulate 
the environmental fate of released substances. 
Molecular mass, vapor pressure, octanol-wa-
ter partition coefficient, water solubility, deg-
radation in air, water, sediment and soil are 
required input data to run the USETox model.  
For toxicity, the program USETox consid-
ers inhalative and oral uptake and splits non-
cancer endpoints from cancer endpoint. Other 
than in workplace risk assessment, damage is 
calculated. For doing so, for each substance 
under consideration an ED50, h has to be de-
fined. The effect factor, EF, is calculated as 
ܧܨ ൌ ଴.ହா஽ఱబ  
where ED50, is the lifetime dose which causes 
a 50 % likelihood of disease. The ED50, h is 
preferably derived from human data, alterna-
tively from data on experimental animals. De-
tails are given in (Rosenbaum et al., 2008, 
2011). USETox splits the ED50 values for can-
cer and non-cancer disease on the one hand, 
and oral and inhalation uptake on the other 
hand. Briefly, for animal data and oral uptake, 
the procedure is 
ܧܦ50௛,௢௥௔௟ ൌா஽ହ଴ೌ,೟,೚ೝೌ೗∗஻ௐ∗௅்∗ே
஺ி೟∗஺ிೌ ∗ଵ଴ల 			ሾ
௞௚
௉௘௥௦௢௡∗௅்ሿ  
with ED50a,t,oral = Dose (mg/kg/d), for species 
a at t exposure time via route j; BW: body 
weight man, 70 kg; LT: life-time, 70 years; N: 
365 days per year; AFt: extrapolation factor 
for study duration, AFt = 2 for sub-chronic to 
chronic and 5 for subacute to chronic extrap-
olation; AFa: Extrapolation animal to man by 
allometric scaling only.  
For inhalation, the calculation runs as fol-
lows: 
ܧܦ50௛,௜௡௛௔௟ ൌ
்஽ହ଴௔,௧,௜௡௛௔௟∗ூேு∗௅்∗ே
஺ி௔∗஺ி௧∗ଵ଴ల 	ሾ
௞௚
௣௘௥௦௢௡∗௅்ሿ  
where INH is the daily inhalation volume for 
man [13 m³/d], and AFa = 1 for inhalation 
data. For cancer endpoints, ED50,h may be de-
rived from available epidemiologic data by 
the use of the cancer slope factor. For animal 
data, the tumorigenic dose TD50 shall be taken 
from the University of Berkeley carcinogen 
potency data base. As a fall back, the TD50 can 
be derived from available animal data.  
For non-cancer endpoints, ED50,a should 
be taken directly from animal data. If the 
study data do not provide chronic ED50 val-
ues, these may be estimated by extrapolation 
factors, which are 
ܧܦହ଴ ൎ ܱܰܣܧܮ ∗ 9,  
or, in absence of a NOAEL, 
ܧܦହ଴ ൎ ܮܱܣܧܮ ∗ 2.5.  
For the route-to-route exposure, extrapo-
lation from inhalation data to oral data can be 
done by using simply a factor of 1 (Rosen-
baum et al., 2011), assuming complete oral 
absorption. Inhalation data are transformed to 
oral data by multiplication with the ventila-
tion rate of the species, which is ଴.଼	௅௠௜௡∗௞௚	௕.௪. for 
the rat (European Chemicals Agency, 2012) 
multiplied with minutes of exposure per day. 
The result for the complete system under in-
vestigation is 
ܫܵ ൌ ∑ ሺܥܨ௜,௢௥௔௟ ∗ ܯ௜,௦௢௜௟,௪௔௧௘௥ ൅௜
ܥܨ௜,௜௡௛ ∗ ܯ௜,௔௜௥ሻ [cases] 
with IS as impact score; estimated increase in 
morbidity factor in the exposed human popu-
lation. Mi,j is the mass of component i 
emitted into compartment j. For the estimated 
number of cases, IS is to be multiplied with 
the number or individuals per exposed popu-
lation.  
 
RESULTS 
Toxicological Profile of the solvents 
Naphtha 1 (CAS-No.: 64742-82-1)  
Data for naphtha 1 are available on the 
European Chemicals Agency (ECHA) web 
EXCLI Journal 2017;16:40-51 – ISSN 1611-2156 
Received: November 09, 2016, accepted: January 04, 2017, published: January 10, 2017 
 
 
44 
site (European Chemicals Agency, 2016c). 
The MAK Commission of the Deutsche For-
schungsgemeinschaft issued a review of 
naphtha 1 in 2016 (Deutsche Forschungsge-
meinschaft, 2016). This group of solvents 
comprises C9 – C16 aliphatic hydrocarbons, 
hydrotreated to remove sulfur compounds. In 
short term exposure tests with volunteers, ex-
posures up to 20 ppm – which was the highest 
concentration tested – were without effects. 
The Deutsche Forschungsgemeinschaft 
(2016) cites a sub-chronic inhalation study 
where rats were exposed for 6 h/d and 5 d/w 
against 0, 359, 737 or 1440 pm C10 – C12 
paraffin. At the highest dose, animals were le-
thargic, and a liver weight increase of 40 % 
was rated as “undesirable”; kidney weight in-
crease in male rats was elevated in all dose 
groups and is regarded as species specific, but 
at the top dose also female rats had signifi-
cantly increased kidney weights. Therefore, 
the Deutsche Forschungsgemeinschaft (2016) 
rated 737 ppm as NOAEC.  
In a sub-chronic gavage study rats re-
ceived 0, 100, 500 or 1000 mg/kg naphtha 
(free of aromatic compounds, boiling point 
range 205 – 237° C) on five days per week for 
13 weeks (Deutsche Forschungsgemein-
schaft, 2016). 500 mg/kg caused increased 
liver weights, changes in clinical parameters 
and increased levels of liver enzymes activity 
in blood. The NOAEL was 100 mg/kg, which 
is also lower than the oral NOAEL of a two-
generation study with rats. 
Exposure of gravid rats during gestation days 
6 to 15 for 6 h/d revealed a NOAEC of 364 
ppm (top dose). 
Aromatic free naphtha was negative in the 
bacterial reverse mutation assay, chromoso-
mal aberration test with CHO cells and the 
mouse lymphoma assay with and without 
metabolic activation (Deutsche For-
schungsgemeinschaft, 2016).  
After intraperitoneal application, kero-
sene free of aromatic compounds increased 
chromosomal aberrations in bone marrow of 
male, but neither in female B6C3F1 mice nor 
in SD rats. Dominant lethal test were negative 
in mice after either s. c. or inhalation applica-
tion, and negative in rats after i. p. application 
(Deutsche Forschungsgemeinschaft, 2016).  
Hydrodesulfurated naphtha showed an in-
conclusive carcinogenic potential in a one 
year inhalation study with rats and mice with 
one year post-exposure observation period. 
Tumor incidences were increased either at the 
top dose of 5000 mg/m³ only in organs with a 
high back-ground incidence, or there was no 
dose-response. 1000 mg/m³ (low dose) 
caused testical atrophy in male, and islet cell 
hyperplasia in female mice without a dose-re-
sponse.  
In a dermal cancer study with mice, hy-
drodesulfurated naphtha was a promotor, but 
not an initiator; when applied in higher, irri-
tating concentrations, the solvent caused skin 
tumors in mice. As the relevance for human 
beings is not clear, the MAK commission 
concluded on a classification as carcinogen 
category 3b (Deutsche Forschungsgemein-
schaft, 2016). 
Based on the above data, and taking hu-
man experience with these and similar sol-
vents into consideration, the DFG issued a 
MAK-value of 50 ppm = 350 mg/m³ as va-
pour (Deutsche Forschungsgemeinschaft, 
2016). 
For a DNEL for consumer inhalation ex-
posure, the NOAEC from a teratogenicity 
study of 364 ppm is taken as point of depar-
ture. A factor of 6 is applied for subacute to 
chronic exposure, 2.5 for remaining inter-spe-
cies differences, a factor of 10 for intra-spe-
cies extrapolation and factors of 24/6 and 7/5 
for exposure time corrections. The result is 
DNELinh, consumer = 0.4 ppm = 3 mg/m³. 
For the oral DNEL for consumers, the 
NOAEL of 100 mg/kg of the sub-chronic ga-
vage study is taken as point of departure. The 
NOAEL is devided by factors of 10 for inter-
species and intra-species extrapolation each, 
and 24/6 and 7/5 to cover daily exposure. A 
factor of 2 is applied for sub-chronic to 
chronic extrapolation. The result is 
DNELoral, consumer = 0.09 mg/kg/d. 
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Naphtha 2 (CAS-No.: 64742-95-6) 
Data concerning naphtha 2 are available 
on the ECHA website (European Chemicals 
Agency, 2016d). However, toxicological data 
looked very similar to those of naphtha 1 (Eu-
ropean Chemicals Agency, 2016c), which im-
plies that a lot of read across was done; as 
both types of solvent are different in compo-
sition – aromatic free hydrocarbons versus ar-
omatic C8-C10 hydrocarbons – the robust-
ness of this read-across cannot be evaluated 
by the authors. Therefore, the following sum-
mary of toxicological data is based on the 
evaluations by the DFG for C9 aromatic mix-
tures (Deutsche Forschungsgemeinschaft, 
1998, 2001). Rats were exposed against 0, 
450, 900 or 1800 mg/m³ C9 aromatic mixture 
for 6 h/d, 5 d/w for 12 months. The NOEC 
was 366 mg/m³ (measured concentration). 
This NOEC is lower than the NOAECs de-
rived from sub-chronic inhalation studies in-
cluding those addressing neurotoxicity, a 
three generation inhalation study with rats as 
well as developmental toxicity studies with 
rats and mice after inhalation exposure.  
C9 aromatic compounds were negative in 
bacterial reverse mutation assay, chromoso-
mal aberration, SCE and HPRT assay in CHO 
cells in vitro. After oral (mice) and inhalation 
exposure (rats), C9 aromatic compounds did 
not cause chromosomal aberrations in bone 
marrow in vivo.  
The DFG issued a MAK-value of 20 ppm 
= 100 mg/m³ (Deutsche Forschungsgemein-
schaft, 1998). 
For the consumer, the DNEL for inhala-
tion is derived from the chronic inhalation 
study. Starting with a NOAEC of 366 mg/m³, 
by applying factors 2.5 for remaining inter-
species differences, and 10 * 24/6 * 7/5 (inter-
species, consumer, continuous exposure) re-
sult in 
DNELinh, consumer = 2.6 mg/m³. 
Benzene (CAS-No. 71-43-2) 
For benzene, ample literature concerning 
its toxicological profile was published by the 
United States National Library of Medicine, 
Integrated Risk Information System (United 
States Environment Protection Agency, 
2016a). For cancer, the human unit risk level 
(one additional case in one million exposed 
over lifetime) is about 3.5 * 10-2 mg/kg/d as 
oral slope factor, and about 5 * 10-6 m³/µg for 
the inhalation slope factor. From these data, 
the ED50, cancer values are derived: 
ED50, inh, cancer  = 33.2 ௞௚௣௘௥௦௢௡	∗	௟௜௙௘௧௜௠௘  
ED50, oral, cancer  = 25.6	 ௞௚௣௘௥௦௢௡	∗	௟௜௙௧௜௠௘ 
For the non-cancer effects, benzene tox-
icity on the hematopoietic system as derived 
from epidemiological studies was taken as the 
critical endpoint. Inhalation data were trans-
formed to oral uptake data. In a Chinese 
worker cohort, benzene exposure correlated 
with reduction in white blood cell, erythro-
cyte and platelet count (Rothman et al., 1996). 
The absolute lymphocyte count showed a 
dose-response, so this effect was chosen to 
derive the non-cancer ED50 values. 
 
Table 3: Dose-response of absolute lymphocyte 
count against benzene exposure in a Chinese co-
hort (Rothman et al., 1996) 
Benzene 
ppm; median (range)
Absolute Lymphocyte 
Count, x 103/µL 
(mean/SD) 
0.02 (0.01 – 0.1) 1.9 / 0.4 
13.6 (1.6 – 30.6) 1.6 / 0.3 
91.9 (31.5 – 328.5) 1.3 / 0.3 
 
Data were modeled with the benchmark 
dose software version 2.5 (U.S. Environmen-
tal Protection Agency). A polynome 2nd de-
gree fitted the data optimal, but it is over-pa-
rameterized. However, it represents the worst 
case as the slope of the curve is steeper in the 
low dose area than for the linear dose-re-
sponse curve: 
ALC = 1.9 – 0.0248 * D + 0.0002 * D². 
The non-cancer ED50, now, is defined as 
the dose that shifts the mean of the ALC to the 
lower 95 % C. I., the ALClow of the “non-ex-
posed” group.  
ALClow = ൏ ܺ ൐ െݐଽହ;ସଷ ∗ ߪ  
ALClow = 1.9 – 1.68 * 0.4 = 1.23. 
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This ALClow is linked to an exposure 
against 40 ppm (129 mg/m³) by the polyno-
mic model. For the ED50 it is assumed that ex-
posure takes place for 8 h per day, and the in-
halation volume for this time period is as-
sumed to be 10 m³ (worker, low to median ac-
tivity). The daily uptake, therefore, is 
1.29 g/d. As for the endpoint cancer it is as-
sumed that there is no difference in uptake be-
tween inhalation and ingestion. As a result, 
for both exposure paths, the non-cancer ED50 
for benzene is 
ED50non-cancer = 1.29 ∗ ଵ଴షయ௞௚ௗ ൌ 33
௞௚
௟௜௙௘௧௜௠௘. 
n-Butyl acetate (CAS-No.: 123-86-4) 
Toxicological data for n-Butyl acetate are 
published on the ECHA website (European 
Chemicals Agency, 2016e); the toxicological 
data were also reviewed by the German 
Deutsche Forschungsgemeinschaft (2003). 
The latter resource is used for the summary of 
toxicological data. 
Tests with volunteers exposed for 4 h 
showed clear throat and eye irritation and 
breathing difficulties at 147 ppm; 15 ppm 
caused some redness of eyes.  
Rats were exposed against 0, 500, 1500 or 
3000 ppm Butyl acetate for 6 h/d for 14 
weeks. 500 ppm was the NOEC; at higher 
concentrations animals showed reduced body 
weight gain, reduced motor activity and seda-
tion. Organs other than the nervous system 
were not investigated.  
A two generation study in rats resulted in 
a NOAEC of 750 ppm for systemic effects. 
This concentration, however, caused local ir-
ritation in the upper respiratory tract (Euro-
pean Chemicals Agency, 2016e). 1500 ppm 
was the NOAEC for teratogenicity in rats, but 
the LOAEC for maternal and fetal toxicity 
(Deutsche Forschungsgemeinschaft, 2003).  
Butyl acetate was negative in the bacterial 
reverse mutation assay and in the in vitro 
chromosomal aberration test (DFG 2003).  
The DFG published a MAK-value of 100 
ppm = 480 mg/m³ (Deutsche Forschungsge-
meinschaft, 2003). 
For the consumer, the DNEL for inhala-
tion is derived from the sub-chronic inhala-
tion study. Starting with a NOEC of 500 ppm, 
by applying factors of 2 for subacute to 
chronic exposure, 2.5 for remaining inter-spe-
cies differences, 10 * 24/6 * 7/5 (inter-spe-
cies, consumer, continuous exposure) result 
in 
DNELinh, consumer = 1.8 ppm = 8.6 mg/m³. 
Ethoxypropylacetate (CAS-No.: 54839-24-6) 
Rats were exposed against 0, 100, 300 or 
1200 ppm Ethoxypropylacetate for 6 h/d, 5 
d/w for 4 weeks (Deutsche Forschungsge-
meinschaft, 2007). The middle and high con-
centration caused altered reactions on exter-
nal stimuli; the NOEC was 100 ppm 
(600 mg/m³). Probably the same study is cited 
on the ECHA website (European Chemicals 
Agency, 2016a). Delayed reactions to exter-
nal stimuli were transient in the middle dose 
group and persisted during exposure only in 
the top dose. The top dose of 1176 ppm 
(measured concentration) was said to be the 
NOAEC due to lack of any histopathological, 
clinical chemistry and hematological effects.  
1-Ethoxy-2-propylacetate was negative in 
the bacterial reverse mutation assay and in the 
in vitro chromosomal aberration test with/out 
metabolic activation (Deutsche Forschungs-
gemeinschaft, 2007). 
The substance is expected to hydrolyze 
rapidly in vivo; the resulting 1-Ethoxy-2-pro-
panol is not toxic to development (Deutsche 
Forschungsgemeinschaft, 2007).  
The DFG published a MAK-value of 50 
ppm = 300 mg/m³ (Deutsche Forschungsge-
meinschaft, 2007). 
For the general population, the DNEL for 
inhalation is derived from the subacute inha-
lation study. Starting with a NOAEC of 1200 
ppm, by applying factors of 6 for subacute to 
chronic exposure, 2.5 for remaining inter-spe-
cies differences, 10 * 24/6 * 7/5 (inter-spe-
cies, consumer, continuous exposure): 
DNELinh, consumer = 8.4 mg/m³. 
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Ethyl-3-ethoxypropionate (CAS-No.:763-69-
9) 
Toxicological data for Ethyl-3-ethoxypro-
pionate can be retrieved from the ECHA web-
site (European Chemicals Agency, 2016b). In 
an oral gavage study, rats received 0, 100 or 
1000 mg/kg Ethylethoxy-propionate 5 d/w for 
4 weeks. 100 mg/kg was the NOEL. 1000 
mg/kg caused slight to moderate increase in 
aspartate amino transferase, alanine amino 
transferase, creatinine and sorbitol dehydro-
genase in blood. In the absence of histopatho-
logical correlates, the authors rate this dose 
level as NOAEL.  
In a sub-chronic inhalation study, rats 
were exposed against 0, 250, 500 or 1000 ppm 
Ethylethoxypropionate 6 h/d, 5 d/w. For male 
rats, body weight was reduced by 5 %, 10 % 
and 15 % for the low, middle and high dose 
group, respectively. Due to absence of histo-
pathological lesions, the authors rate 500 ppm 
(3000 mg/m³) as NOAEC.  
In a teratogenicity study, pregnant rats 
were exposed against 125, 250, 500, and 1000 
ppm Ethylethoxypropionate during gestation 
days 6 to 15. The NOAECs for maternal tox-
icity, fetotoxicity and teratogenicity were 
250, 500 and 1000 ppm respectively.  
Ethylethoxypropionate was not muta-
genic in the bacterial reverse mutation assay 
and the chromosomal aberration assay and 
HPRT assay in CHO cells. 
For the inhalation route, the registrants of 
Ethylethoxypropionate propose a DNEL of 
610 mg/m³ for workers and 72.6 mg/m³ for 
the general population, based on irritation ef-
fects. However, 500 ppm caused a 10 % body 
weight decrease in the sub-chronic inhalation 
study in males, and in the teratogenicity 
study, 250 ppm were identified as maternal 
NOAEC; for that reason, 250 ppm – the 
NOEC of the sub-chronic study – should be 
taken as starting point for the DNEL. For 
workers, a factor of 2.5 is used for remaining 
inter-species differences (toxicodynamic fac-
tor rat to man), a factor of 5 (worker) or 10 * 
24/6 * 7/5 (consumer) for intra-species ex-
trapolation and a factor of 2 for sub-chronic to 
chronic extrapolation. The results are  
DNELinh, worker  = 120 mg/m³; 
DNELinh, consumer  = 11 mg/m³. 
For oral uptake, the DNEL for the general 
population is 1.2 mg/kg/d (assessment factor 
600 for the subacute oral NOAEL, multiplied 
by 5/7 for daily exposure). 
 
Worker Risk Assessment 
Exposure estimates for the different sol-
vents as delivered by the Advanced REACH 
Tool (McNally et al., 2014) are summarized 
in Table 4. For the naphta solvents 1 and 2, 
due to the classification and labeling provided 
in the safety data sheets, the content of ben-
zene must be below 0.1 %. From the produc-
tion of the solvents it is to be expected that 
some benzene is present. As the actual content 
of benzene in naphtha 1 and 2 is unknown to 
the authors, the benzene content is estimated 
as 0.05 % in the respective naphtha solvent, 
which makes 0.008 % in the varnish (0.16 * 
0.05 %). 
Based on calculated median exposure 
concentrations, for the two different formula-
tions, the Hazard Index ܪܫ ൌ ∑ ஼೔ெ஺௄೔ is 0.046 
for solvent Formulation 1 and 0.037 for sol-
vent Formulation 2. However, if benzene is 
present at about 0.008 % in Formulation 1, the 
calculated mean exposure against 0.64 µg/m³ 
benzene would give reason to an additional 
cancer incidence of 32 cases in 10000 persons 
exposed over lifetime.  
 
Life Cycle Assessment, impact category  
toxicity 
The intake fraction (iF), fate and distribu-
tion of a substance is calculated with the pro-
gram USETox. Measured data on ready bio-
degradability were available for all com-
pounds, and these were transformed to 
aquatic halves lives according to the REACH 
Guidance (European Chemicals Agency, 
2014). The naphtha components were readily 
degradable, but missed the 10 d windows. 
Degradation rates in air, sediment and soil 
were calculated with the US EPA Episuite 
program version 4.1 (United States Environ-
ment Protection Agency, 2016b). For the 
naphta products, a representative molecule 
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had to be chosen for the EPISUITE program 
to run, which was decane for naptha 1, and 4-
ethyl-methylbenzene for naphta 2. N-Bu-
tylacetate was listed in the USETox 2.0 data-
base already. For the remaining substances, 
data are summarized in Table 5. Due to the 
toxicological profiles described in chapter 
3.2, ED50 values were derived for non-cancer 
endpoints, only (Table 6) – with the exemp-
tion of benzene. As either 10 kg Formulation 
1 or 13.75 kg Formulation 2 are applied per 
day, the solvents contained are assumed to be 
emitted within one day. The characterization 
factor CF, cases per kg emitted, were calcu-
lated for emission into urban air in Europe. 
The results are listed in Table 7.  
The total proportion of disease cases in a 
population can be estimated by summing up 
the emissions over all working days in 70 
years life time – 240 working days per year – 
multiplied by the substance specific charac-
terization factors.  
ܫܵி௢௥௠௨௟௔௧௜௢௡ ൌ ∑ ܥܷܶ௛,௜ ∗ ܯ ቂ௞௚ௗ ቃ ∗௜
240 ቂௗ௬ቃ	 ∗ 70 ቂ
௬
௟௜௙௘௧௜௠௘ቃ	;	  
ISFormulation 1  = 4.6 * 10-4 [cases]; 
ISFormulation 1+  = 7.2 * 10-3 [cases]; 
ISFormulation 2  = 1.5 * 10-4 [cases]. 
 
 
Table 4: 25-, 50- and 75-percentiles of exposure estimates for workers handling the reactive varnish, 
calculated with the Advanced REACH Tool (ART) 
Substance CAS-No. 
mg/m³ 
25-P 50-P 75-P MAK / DNEL 
n-Butylacetate 123-86-4 1,7 3,5 7,4 480 
Ethoxypropyl-acetate 54839-24-6 0,74 1,5 3,1 300 
Ethyl-3-ethoxy-propionate 763-69-9 0,32 0,65 1,4 120 
naphtha 1 64742-82-1 1,2 2,5 5,2 350 
naphtha 2 64742-95-6 0,73 1,5 3,1 100 
(benzene)1) 71-43-2 0.32 0.64 1.3 --- 
1) assumed to be present in Formulation 1 at a concentration of 0.008 %  
 
 
Table 5: First order degradation rate constants in air, water, sediment and soil, octanol-water partition 
coefficient, vapor pressure, solubility in water and Henry constant 
Substance kair [s-1] 
kwater 
[s-1] 
ksed 
[s-1] 
ksoil 
[s-1] KOW 
VP [Pa, 
298 K] 
Sol 
[mg/L, 
298 K] 
H 
ሾࡼࢇ∗࢓૜࢓࢕࢒ࢋ ሿ 
n-Butyl-ace-
tate 5.3E-06 2.8E-04 1.5E-07 6.7E-07 60 1500 5.3E03 28.5 
Ethoxy-propyl-
acetate 2.5E-05 2.8E-04 8.6E-08 3.9E-07 16 517 2.0E05 0.39 
Ethyl-3-eth-
oxy-propio-
nate 
2.5E-05 2.8E-04 8.6E-08 3.9E-07 30 230 5.4E04 0.72 
naphtha 1 1.3E-05 8.3E-05 1.5E-07 6.7E-07 1E+05 231 0.052 5.2E05 
naphtha 2 1.3E-05 8.3E-05 8.6E-08 3.9E-07 4.3E+03 384 75 5.1E02 
benzene 9.2E-07 2.1E-07 2.4E-08 1.1E-07 2.12 1.3E04 1.8E03 561 
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Table 6: ED50 values of the solvents 
Substance 
NOAELchr 
oral 
[mg/kg] 
NOAELchr 
inh 
[mg/m³] 
ED50(a) 
oral 
[mg/kg] 
ED50 (a) 
inh 
[mg/m³] 
ED50 (h) 
oral 
[kg/case] 
ED50 (h) 
inh 
[kg/case] 
n-Butyl acetate 344 1194 3096 10746 1384 19219 
Ethoxypropyl-acetate 414 1440 3726 12960 1666 23179 
Ethyl-3-ethoxy-propio-
nate 20 750 180 6750 81 12072 
naphtha 1 50 54,6 450 491,4 201 879 
naphtha 2 53 183 477 1647 213 2946 
benzene1) - - - - 25.6 | 332) 33.2 | 332) 
1) benzene see chapter “Benzene”; 2) cancer | non-cancer 
 
Table 7: Emission into the air per day, depending on formulation 
Solvent CAS-No. Formulation content  [%] 
emission M  
ሾ࢑ࢍࢊ ሿ 
CTUh  
ሾ ࢉࢇ࢙ࢋ࢙࢑ࢍࢋ࢓࢏࢚࢚ࢋࢊሿ 
 
n-Butylacetate 123-86-4 2 10 1.375 1.3E-09 
Ethoxypropyl-acetate 54839-24-6 2 6 0.825 1.3E-09 
Ethyl-3-ethoxy-propionate 763-69-9 2 6 0.825 7.2E-09 
naphtha 1 64742-82-1 1 8 0.8 2.6E-08 
naphtha 2 64742-95-6 1 8 0.8 8.3E-09 
(benzene)1) 71-43-2 1 (0.008) (0.08) (5.0E-06)1)
1) details for benzene see chapter “Benzene”; CTUh combined for cancer and non-cancer; 
 
 
It is debatable whether or not benzene has 
to be included into Formulation 1. As a matter 
of fact, benzene might be present in naphtha 
1 and naphtha 2 due to their origin. As the 
products were not labeled as carcinogenic and 
mutagenic, the content must be below 0.1 %. 
If benzene is present at 0.008 % (Formulation 
1+), the impact score for toxicity of the de-
signed operation increases by a factor of 
about 16. 
 
DISCUSSION 
The comparative toxicity of two formula-
tions of a reactive varnish that differ in the 
qualitative and quantitative content of sol-
vents was assessed. This assessment was done 
against workplace risk assessment on the one 
hand, and the Life Cycle Assessment Impact 
Category “Toxicity” on the other hand. The 
exposure scenario was defined as spreading 
10 kg (Formulation 1) or 13.75 kg (Formula-
tion 2) varnish over 10 m² during 6 h per 
working day. 
For the worker risk assessment, when the 
potential content of benzene in Formulation 1 
is not covered, in general both formulations 
can be used in a safe way for the exposure sce-
nario outlined. Individual exposure limits are 
not exceeded, and also the combined expo-
sure is not expected to cause considerable 
damage to health. “What if” scenarios might 
be discussed, for example concerning adverse 
outcomes in accidental situations where the 
exposure limits are not met. Both formula-
tions contain substances that are labeled as 
causing drowsiness and dizziness and skin ir-
ritation. The naphtha formulation components 
are additionally classified as fatal if swal-
lowed – which should not be a realistic prob-
lem at workplaces – and as affecting the nerv-
ous system. The latter might be regarded as 
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relatively critical, which calls for a substitu-
tion of Formulation 1 by Formulation 2.  
If benzene is present at 0.008 % in Formu-
lation 1, the calculated exposure is 0.64 (me-
dian or 50-percentile) or 1.3 mg/m³ (75-per-
centile). Robbins et al. (2013) demonstrated 
that wiping exercises with solvents containing 
0.1 % benzene led to a measured exposure of 
about 0.49 mg/m³, and the ratio of calculated 
to measured exposure ranged from 0.42 to 
2.1. Exposure against 1.3 mg/m³ benzene is 
related to an excess cancer incidence of 32 in 
10000 exposed persons. For carcinogens, the 
DMEL according to the ECHA guidance doc-
ument (European Chemicals Agency, 2012) 
shall not exceed 1 case in 100,000 to 1 million 
exposed. Therefore, this aspect would call for 
a substitution of Formulation 1 against For-
mulation 2. This result would also call for 
specific limits for benzene in formulations for 
classification and labelling below the current 
European Union generic limit of 0.1 %. 
In Life Cycle Assessment, toxicity is one 
of the potential impact categories that can be 
addressed. One way to do so is provided by 
the publicly available program USETox (Ros-
enbaum et al., 2008, 2011). There are certain 
differences to the workplace risk assessment: 
the compound under investigation is emitted 
into environmental compartments; in these 
environmental compartments it undergoes 
distribution and degradation processes; de-
pending on distribution and degradation pro-
cesses, certain concentrations will show up in 
air, drinking water and food, and finally be 
taken up by inhalation and ingestion; the 
model than calculates potential damage as 
disease cases per kg substance emitted. The 
fate of the emitted substance is estimated with 
multimedia environmental models. The 
choice of a region addresses the different en-
vironmental parameters that dictate the degra-
dation of a substance, like sunlight intensity, 
rain and temperature; the program makes use 
of the mean values of climate parameters in 
the region. Toxicity is translated into disease 
cases per kg emitted. Disease is split up in 
“cancer” and “non-cancer” without further 
detail. As there are uncertainties concerning 
the environmental fate as well as concerning 
extrapolation factors in toxicity and subse-
quent disease, the final outcome is appropri-
ately called “potential” cases per kg; it is more 
are ranking tool for substances and not meant 
to be a prediction in expected disease inci-
dence. For the substance ranking, a difference 
of up to a factor of 1000 is not necessarily an 
indicator for detectable higher / lower toxicity 
(Rosenbaum et al., 2008). Against that back-
ground, the differences between Formulation 
1 (with and without benzene) and Formula-
tion 2 are not convincing for a substitution. 
Further, for a complete picture of the toxicity 
potential in Life Cycle Assessment, the up-
stream processes, e. g. toxicity potentials of 
emissions due to the production processes of 
the solvents, need to be covered as well. This 
would require the (public) availability of Life 
Cycle Inventory data of all upstream pro-
cesses, which is the case for the naphtha sol-
vents only.  
Over all, for workplace safety reasons the 
substitution of Formulation 1 by Formulation 
2, as the presence of benzene is likely, is rec-
ommended. Such a substitution would also 
lower the toxicity potential in the Life Cycle 
Assessment of the product.  
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